Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and efficacy of aviandr in patients with generalized anxiety disorder: A multicenter, randomized, double-blind, placebo-controlled, dose-finding, pilot study.
Ivashchenko AA, Morozova MA, Vostokova NV, Beniashvily AG, Bukhanovskaya OA, Burminskiy DS, Egorova AN, Gluskina LY, Gorchakov DS, Karapetian RN, Kasimova LN, Kravchenko DV, Lepilkina TA, Merkulova EA, Mitkin OD, Penchul NA, Potanin SS, Rupchev GE, Ivachtchenko AV. Ivashchenko AA, et al. Among authors: ivachtchenko av. J Psychiatr Res. 2021 Nov;143:436-444. doi: 10.1016/j.jpsychires.2021.10.008. Epub 2021 Oct 11. J Psychiatr Res. 2021. PMID: 34656876 Clinical Trial.
Add-on clinical effects of selective antagonist of 5HT6 receptors AVN-211 (CD-008-0173) in patients with schizophrenia stabilized on antipsychotic treatment: pilot study.
Morozova MA, Lepilkina TA, Rupchev GE, Beniashvily AG, Burminskiy DS, Potanin SS, Bondarenko EV, Kazey VI, Lavrovsky Y, Ivachtchenko AV. Morozova MA, et al. Among authors: ivachtchenko av. CNS Spectr. 2014 Aug;19(4):316-23. doi: 10.1017/S1092852913000394. Epub 2013 Jun 17. CNS Spectr. 2014. PMID: 23768250 Clinical Trial.
AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical Trial.
Ivashchenko AA, Dmitriev KA, Vostokova NV, Azarova VN, Blinow AA, Egorova AN, Gordeev IG, Ilin AP, Karapetian RN, Kravchenko DV, Lomakin NV, Merkulova EA, Papazova NA, Pavlikova EP, Savchuk NP, Simakina EN, Sitdekov TA, Smolyarchuk EA, Tikhomolova EG, Yakubova EV, Ivachtchenko AV. Ivashchenko AA, et al. Among authors: ivachtchenko av. Clin Infect Dis. 2021 Aug 2;73(3):531-534. doi: 10.1093/cid/ciaa1176. Clin Infect Dis. 2021. PMID: 32770240 Free PMC article. Clinical Trial.
Effect of Aprotinin and Avifavir® Combination Therapy for Moderate COVID-19 Patients.
Ivashchenko AA, Azarova VN, Egorova AN, Karapetian RN, Kravchenko DV, Krivonos NV, Loginov VG, Poyarkov SV, Merkulova EA, Rosinkova OS, Savchuk NP, Topr MA, Simakina EN, Yakubova EV, Ivachtchenko AV. Ivashchenko AA, et al. Among authors: ivachtchenko av. Viruses. 2021 Jun 27;13(7):1253. doi: 10.3390/v13071253. Viruses. 2021. PMID: 34199134 Free PMC article.
Crystal structure, Hirshfeld analysis and a mol-ecular docking study of a new inhibitor of the Hepatitis B virus (HBV): ethyl 5-methyl-1,1-dioxo-2-{[5-(pentan-3-yl)-1,2,4-oxa-diazol-3-yl]meth-yl}-2H-1,2,6-thia-diazine-4-carboxyl-ate.
Ivachtchenko AV, Kovalenko SM, Kravchenko DV, Mitkin OD, Ivanov VV, Langer T. Ivachtchenko AV, et al. Acta Crystallogr E Crystallogr Commun. 2020 Jan 1;76(Pt 1):12-17. doi: 10.1107/S2056989019015986. eCollection 2020 Jan 1. Acta Crystallogr E Crystallogr Commun. 2020. PMID: 31921445 Free PMC article.
The Efficacy of Aprotinin Combinations with Selected Antiviral Drugs in Mouse Models of Influenza Pneumonia and Coronavirus Infection Caused by SARS-CoV-2.
Ivashchenko AA, Zagribelnyy BA, Ivanenkov YA, Ivashchenko IA, Karapetian RN, Kravchenko DV, Savchuk NP, Yakubova EV, Ivachtchenko AV. Ivashchenko AA, et al. Among authors: ivachtchenko av. Molecules. 2022 Aug 5;27(15):4975. doi: 10.3390/molecules27154975. Molecules. 2022. PMID: 35956925 Free PMC article.
Synthesis, X-ray crystal structure, Hirshfeld surface analysis, and molecular docking study of novel inhibitor of hepatitis B: methyl 4-fluoro-3-(morpholinosulfonyl)benzo[b]thiophene-2-carboxylate.
Ivachtchenko AV, Mitkin OD, Kravchenko DV, Kovalenko SM, Shishkina SV, Bunyatyan ND, Konovalova IS, Dmitrieva IG, Ivanov VV, Langer T. Ivachtchenko AV, et al. Heliyon. 2019 Nov 14;5(11):e02738. doi: 10.1016/j.heliyon.2019.e02738. eCollection 2019 Nov. Heliyon. 2019. PMID: 31844693 Free PMC article.
Non-rigid Diarylmethyl Analogs of Baloxavir as Cap-Dependent Endonuclease Inhibitors of Influenza Viruses.
Ivashchenko AA, Mitkin OD, Jones JC, Nikitin AV, Koryakova AG, Ryakhovskiy A, Karapetian RN, Kravchenko DV, Aladinskiy V, Leneva IA, Falynskova IN, Glubokova EA, Govorkova EA, Ivachtchenko AV. Ivashchenko AA, et al. Among authors: ivachtchenko av. J Med Chem. 2020 Sep 10;63(17):9403-9420. doi: 10.1021/acs.jmedchem.0c00565. Epub 2020 Aug 17. J Med Chem. 2020. PMID: 32787099
75 results